INTRODUCTION
Hydrolysis of hepatic intracellular triacylglycerol (TG) 3 stores generates substrates for β-oxidation and lipid re-synthesis, some of which are utilized for the assembly of very-low-density lipoproteins (VLDL) (1) (2) (3) . The assembly of VLDL involves both co-translational and posttranslational addition of lipids to apolipoprotein B (apoB) (4) (5) (6) (7) . The transfer of lipids to nascent apoB particles is facilitated by the microsomal triglyceride transfer protein (MTP) (8, 9) . MTP is also responsible for the formation of apoB-free endoplasmic reticulum (ER) lumenal lipid droplets (10) (11) (12) . These lipid droplets are believed to serve as lipid donors for bulk lipidation of primordial apoB-containing particles (10) (11) (12) (13) . One enzyme that has been implicated to play a role in the hydrolysis of stored TG pools and assembly of VLDL is an ER associated triacylglycerol hydrolase (TGH) (14) (15) (16) (17) (18) (19) (20) . Inhibition of TGH leads to decreased TG mobilization and apoB secretion from hepatocytes (15) . However, treatment of hepatocytes with a TGHspecific inhibitor reduced secretion of TG and apoB to a lesser extent than the general lipase inhibitor, diethyl-p-nitrophenyl phosphate (E600), suggesting that other lipases may also contribute to VLDL assembly (15) . The fact that perinatal rat hepatocytes are capable of TG secretion in the absence of TGH expression in this particular developmental stage provides further support for the existence of additional lipases (21, 22) .
In addition to VLDL assembly, fatty acids released from intracellular stores can be utilized for energy production via β-oxidation in the mitochondria. Unlike the well-described roles of adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) in the mobilization of TG stores in adipose tissue (23) (24) (25) (26) , the identity of hepatic lipases supporting β-oxidation is still unclear. Arylacetamide deacetylase (AADA) shares sequence homology with 
Cell culture and generation of McA cell lines stably expressing AADA-FLAG cDNA
McA cells, obtained from ATCC, were cultured in DMEM containing 50 U/mL penicillin/streptomycin, 10% horse serum and 10% fetal bovine serum at 37ºC in humidified air containing 5% CO 2 . Wild-type McA cells were transfected with 6 µg of empty vector pCI-neo (pNeo) or AADA-FLAG-pCI-neo using Lipofectamine2000. prepared from post-nuclear supernatants by 1 h centrifugation at 106,000 g. Microsomes containing radiolabeled lipids were suspended in homogenization buffer and incubated for up to 4 hours at 37°C. Lipids were extracted and radioactivity PC, diacylglycerol (DG), fatty acids (FA) and TG were determined following thin-layer chromatography as described below.
Measurements of oleic acid incorporation into cellular lipids
McA pNeo, A13 and A23 cell lines were grown to ~70% confluency in 60 mm culture dishes. Cells were incubated for 4 h with 2 mL of serum-free DMEM containing 0.4 mM oleic acid (OA) complexed to 0.4% BSA (14) in the presence or absence of 100 µM E600. After 4-h OA loading, cells were washed with ice-cold PBS, harvested in 2 mL of the same buffer, and disrupted by sonication. Lipids from cell lysates were extracted and TG, cholesteryl esters (CE) and phospholipids (PL) were quantified by gas chromatography (32) .
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Metabolic labelling studies
McA pNeo, A13 and A23 cell lines were grown to ~70% confluency in 60 mm culture dishes. Cells were pulse-labeled for 4 hours with 2 mL of serum-free DMEM containing 0.4 mM OA complexed to 0.4% BSA and [9,10(n)-³H]OA as radiolabeled tracer to stimulate neutral lipid synthesis. Some dishes from each cell line contained 100 µM E600 to inhibit lipase activity. After 4 h pulse, some cells and media were collected for analyses. For the remaining dishes of cells, the pulse media were aspirated, cells were washed 3 times with serum-free DMEM containing 0.4% fatty acid free BSA, then incubated with 2 mL of serum-free DMEM for additional 4 h, which represented the 4 h chase period. Some dishes from each cell line were also incubated in the presence of 100 µM E600 to inhibit lipase activity. After 4 h chase, cells and media were collected for analyses as described above. The media were centrifuged at 2500 g for 5 min to remove cell debris. All cells were washed with ice-cold PBS, harvested in the same buffer, and disrupted by sonication. Cellular and media lipids were extracted by the method of Folch et al. (33) in the presence of lipid carriers. The lipids were spotted on thin-layer chromatography plates and resolved with a two-solvent system as described previously (14, 15) before visualization by exposure to iodine. Incorporation of radioactivity into TG, CE and phosphatidylcholine (PC) were recovered and their radioactive contents were determined by scintillation counting.
Fatty acid oxidation measurements
Media obtained from the metabolic labelling studies were analyzed for content of acidsoluble metabolites (ASM) released from the cells during β-oxidation. Thirty µL of 20% BSA and 16 µL of 70% perchloric acid were added to 200 µL of culture media from each cell line.
Media were then centrifuged at 25,000 g for 5 min before an aliquot of the supernatant was counted for radioactivity. These experimental conditions were adapted from studies conducted by Hansson et al (34) .
Secretion of apoB
Media were collected at the end of 4 h OA loading and then centrifuged at 2,500 g for 10 min to isolate cell debris. ApoB was immunoprecipitated from media equivalent to 0. complete Freund's adjuvant followed by 3 booster injections of 0.2 mg of the conjugated peptide at 3-week intervals. Pre-immune and anti-AADA sera were prepared, aliquoted and stored at -80°C.
Immunoblotting of AADA
Proteins were resolved by SDS-PAGE, transferred to nitrocellulose membranes and immunoblotted. All membranes were blocked with 5% skim milk in T-TBS for 1 h prior to antibody incubations. All antibody incubations were carried out in 1% skim milk solution in T-TBS. Cellular membrane proteins prepared from McA cell lines or mouse liver homogenates were separated by 10% polyacrylamide SDS gels and transferred to nitrocellulose membranes.
The membranes were blocked with TBS-0.1% Tween 20-5% milk and then were incubated with:
1:10,000 dilution of mouse anti-FLAG primary antibodies followed by 1:10,000 dilution of horseradish peroxidase-conjugated goat anti-mouse secondary antibodies, or 1:1000 dilution of rabbit anti-AADA primary antibodies or 1:10,000 dilution of rabbit anti-Calnexin primary antibodies followed by 1:10,000 dilution of horseradish peroxidase-conjugated goat anti-rabbit secondary antibodies. All immunoblots were exposed to BioMax MR film after using ECL Western Blotting Detection Reagents.
Glycopeptidase F (PNGase F) and Endoglycosidase H (Endo H) treatments
For PNGase F treatment, cell lysates were prepared from the PNGase F and the other half with 2 µL of Tris buffer (control). Samples were incubated overnight at 37 ºC for deglycosylation, then boiled in 1X SDS-PAGE loading buffer and resolved by 10 % SDS-PAGE. AADA was visualized by immunoblotting with anti-AADA sera.
For Endo H treatments, cell lysates were prepared from the A13 McA cell line by homogenization in TBS containing 2 % Triton X-100. One hundred µL of 100 mM sodium citrate, pH 5.5, were added to 100 µL of cell lysates followed by 10 µL (50 mU) of Endo H to half of each sample and 10 µL of sodium citrate buffer (control) were added to the other half.
Samples were incubated overnight at 37 ºC for deglycosylation. Samples were boiled for 5 min in 1X SDS-PAGE loading buffer and resolved by 10 % SDS-PAGE. AADA was visualized by immunoblotting with anti-AADA sera.
Animal Care
All procedures were approved by the Animal Care and Use Committee at the University of Alberta and were in accordance with guidelines of the Canadian Council on Animal Care.
Male adult mice from C57BL/6J background were used for experiments. Mice were fed ad libitum a chow diet (Lab Diet, PICO Laboratory Rodent Diet 20) and were exposed to a 12 h light/dark cycle starting at 8.00 am. Hepatocytes were prepared in the morning from fed mice by collagenase perfusion of the livers.
Confocal immunofluorescence imaging
Mouse hepatocytes isolated from wild type C57BL/6J mice were grown on collagen coated coverslips in 6-well dishes with DMEM containing 10% HS and 10% FBS overnight.
Cells were fixed with 4% paraformaldehyde in PBS for 10 min at room temperature, 
Statistical analysis
Comparisons between three groups (control and two AADA-expressing cell lines) were analyzed by one-way ANOVA using the software GraphPad PRISM ® 4. All values are presented as means ±SD. Statistically significant differences between means were denoted as those with values of *p< 0.001 and **p<0.01 and ***p<0.05.
RESULTS
Localization of AADA in mouse liver and expression of FLAG-tagged AADA in McA cells
AADA colocalizes with a known ER marker protein disulfide isomerase (PDI) in primary mouse hepatocytes as determined by indirect immunofluorescence staining and confocal microscopy ( Fig. 1A) . The ER localization was confirmed by Nycodenz density fractionation of mouse liver homogenate, where AADA co-fractionated with another ER resident protein calnexin (CNX) and was absent from Golgi fractions containing TGN-38 (Fig. 1B) . Mouse AADA cDNA encoding the FLAG epitope engineered just prior to the stop codon was cloned into a pCI-neo plasmid and stably transfected into McA cells, which do not express endogenous AADA ( Fig. 1C and E) . Immunoblots of total cell membrane fractions prepared from FLAGtagged AADA expressing McA cells with anti-FLAG antibodies (Fig. 1D) and with antibodies raised against the C-terminal 14 amino acid peptide of mouse AADA (Fig. 1E) revealed an immunoreactive band of expected molecular mass (50 kDa) that was not present in membranes isolated from the empty vector transfected McA ( Fig. 1D and E) . The levels of AADA protein in the two cell lines used for further experiments (cell lines A13 and A23) were significantly lower than that present in mouse liver fractions (Fig. 1E) cDNA. A13 and A23 microsomal fractions exhibited increased esterase activities against both of these substrates ( Fig. 2A, B) . (Fig. 2D) . This result strongly suggests that the expressed AADA is a catalytically active esterase and that the observed increases in in vitro activities against artificial and native substrates are due to the enzymatic activity of AADA rather than to its potential auxiliary role in hydrolysis. McA cells stably transfected with human TGH cDNA were utilized as a positive control for the FP-biotin reactivity since TGH is a known active serine esterase and has been previously identified in FPlabeling studies (29) .
AADA expressing McA cells accumulate less intracellular TG
Four-hour pulse incubations of pNeo cells with 0.4 mM [ 3 H]OA led to cellular accumulation of radiolabeled TG (Fig. 3A) . However, AADA expressing cells contained significantly less TG than the control pCI-neo cells (~40% decrease, p<0.001). Differences in intracellular TG were abolished when the incubation mixture was supplemented with the lipase inhibitor E600 (Fig. 3A) , indicating that the decrease in TG levels in AADA expressing cells was due to lipolytic activity of the enzyme rather than any possible effect(s) on fatty acid uptake and/or triacylglycerol synthetic enzymes. Fatty acid uptake into the pNeo and AADA cells was About 42% of the radiolabeled TG was depleted in the 4 hour chase, and this turnover rate was similar in the control and AADA expressing cells (Fig. 3A) , indicating that AADA did not likely participate in the turnover of preformed TG stores, but acted on newly synthesized lipids.
Continued inclusion of E600 in the 4 h chase period has also inhibited turnover of preformed TG.
The reduction in TG labeling was also reflected by the decrease in total TG mass in AADA-expressing cells after treatment with 0.4 mM OA for 4 h when compared to control cells.
In agreement with the results from metabolic labeling studies, both AADA cell lines were found to store significantly less intracellular TG (Fig. 4A) . Similarly, addition of E600 was able to abolish the difference in intracellular TG levels between AADA and control cell lines. While a difference in intracellular TG accumulation between AADA-expressing and control cells was observed, intracellular CE levels increased about 200% in all cell lines in the presence of exogenous OA and did not differ among cell lines (Fig. 4B) whereas phospholipid (PL) levels remained relatively constant (Fig. 4C) . These results further support the role of AADA in the regulation of cellular TG levels.
ApoB and TG secretion is decreased as a result of AADA expression in McA cells
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The observed decrease in intracellular TG levels in AADA expressing cells could have been due to increased secretion of this lipid as part of apoB-containing lipoproteins. Therefore, we wished to determine whether AADA expressing cells secreted more TG in apoB-containing particles. Densitometry analysis of immunoblots of media apoB revealed that expression of AADA led to decreased apoB100 secretion ( Fig. 5A and B) . In addition, analyses of media lipids from metabolic labelling studies showed that TG secretion was also lower in AADA expressing cells (Fig. 5C) 
Increased fatty acid oxidation in AADA expressing cells
In order to determine whether the released fatty acids from newly made TG were utilized for fatty acid oxidation the amount of acid soluble metabolites (ASM) released into the media at the end of 4 h pulse/chase experiments was quantified. ASM release reflects the level of fatty acid oxidation in cells. The level of ASM in media was augmented upon expression of AADA, which indicated an increase in fatty acid oxidation due to AADA expression (Fig. 6) . During the 4 hour chase period in the absence of exogenous fatty acids, the levels of fatty acids released from preformed stores for oxidation decreased by a similar percentage among the cell lines, suggesting that AADA has either no role or a very minor role in the mobilization of preformed TG stores for this process. Inclusion of E600 during the pulse incubations ablated the increase in β-oxidation in AADA cells, and the resultant ASM levels were similar in both control and AADA cells. Thus, it appears that in the presence of exogenous fatty acids, AADA activity provided additional 20% of the total fatty acids destined for β-oxidation, which was derived from hydrolysis of newly formed TG stores, and this mobilization could be blocked by lipase inhibitors. Since the delivery of exogenous fatty acids for β-oxidation in the presence of E600 is the same in control and AADA cells, this result provides additional evidence that fatty acid uptake by both control and AADA cells is similar, as seen in the cell labelling and lipid mass studies ( Fig. 3C and Fig. 4B , respectively).
DISCUSSION
Increased flux of fatty acids to the liver from adipose tissue during fasting is a physiologically important process and the liver readily metabolizes this energy source to maintain homeostasis. Fatty acids that enter the liver are re-esterified into triacylglycerol stores, which supply substrates for the assembly of VLDL, or are utilized for β-oxidation. Both processes result in the provision of substrates that are used by other tissues during food deprivation. Ketone bodies that are formed from β-oxidation supply the brain with an energy source, and hepatic VLDL secretion provides fatty acids for energy production in the muscles.
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process that involves lipolysis and re-esterification (1-3). Although the mobilization of TG for VLDL secretion may represent an important regulatory step, there is paucity of information at the molecular level regarding the lipases responsible for this process. A well-studied adipose tissue lipase HSL is not appreciably expressed in the liver (36) . Ectopic expression of this enzyme in hepatocytes resulted in increased mobilization of TG stores, and the released fatty acids were delivered to mitochondria for β-oxidation rather than for re-esterification and VLDL assembly (37, 38) . Another recently identified lipase, ATGL, has much broader tissue expression profile than HSL (23); however, its hepatic expression is also very low and the role of this enzyme in hepatic lipid metabolism remains unknown (24) . ATGL is activated by a lipid dropletbinding protein CGI-58 (39) and recent studies showed that over-expression of CGI-58 in McA cells increased VLDL secretion (40, 41) . It is currently unclear whether the CGI-58-mediated effect is due to the regulation of ATGL that may be expressed in these cells, or through another yet unidentified mechanism. From studies on HSL and ATGL over-expression in hepatic cells (37, 38) , it is obvious that the localization of the lipases may determine the fate of the released fatty acids. Thus, hydrolysis of TG stores by cytosol-oriented lipases such as HSL and ATGL may channel fatty acids to mitochondria for oxidation (37, 38) , while release of fatty acids in the ER could result in re-esterification of the lipolytic products by ER-localized acyltransferases to support VLDL production. To date, two potential ER-localized lipases have been identified, AADA and TGH. While a positive role of TGH in hepatic VLDL assembly has been documented (14) (15) (16) (17) 20) , very little is known about the function of AADA. AADA was initially characterized through its drug transforming ability in vitro (27) . Given its sequence homology to HSL including conserved lipase/esterase catalytic triad residues and its primary expression in organs responsible for lipid metabolism, AADA was hypothesized to have a role in hepatic lipid metabolism (28) . Because HSL can hydrolyze a vast array of carboxylester substrates, including DG, TG, CE as well as artificial esters (42) Although AADA shares similarity with HSL and like HSL showed hydrolytic activity towards endogenously synthesized DG we did not observe any in vitro activity of AADA towards membrane associated TG or CE. Interestingly, AADA shares about 40% sequence identity (including 100% identity in the catalytic domain) with murine arylacetamide deacetylase-like 1 (also known as mKIAA1363 protein), which has been recently reported to possess cholesteryl ester hydrolase activity (43) . Based on our findings we propose a model where AADA hydrolyzes DG synthesized within the ER compartment (Fig. 7) . However, we cannot eliminate the possibility at this time that AADA hydrolyzes other intermediates formed in the glycerol-3-phosphate pathway of glycerolipid synthesis. While DG is also a precursor for TG, PC and phosphatidylethanolamine synthesis, we did not observe any changes in PC levels or PC synthesis in AADA-expressing cells. There is a precedent where ablation of enzyme activities within the glycerol-3-phosphate pathway lead to decreased TG but not glycerophospholipid synthesis. This has been observed through studies in mice deficient in the expression of glycerol-3-phosphate acyltransferase, acylglycerol-3-phosphate acyltransferase and phosphatidic acid phosphohydrolase/lipin 1 (44) (45) (46) . This can be explained by the presence of additional genes encoding duplicate catalytic activities for glycerolipid synthesis via the glycerol-3-phosphate pathway (46) (47) (48) (49) . It is also possible that AADA might hydrolyze acylglycerol intermediates but enough DG is still produced to support the necessary glycerophospholipid synthesis, but not enough of this substrate is present to augment TG synthesis, which takes place when fatty acids and diacylglycerols are in excess. Another possibility would be that rather than hydrolyzing carboxylic esters, AADA could also function as a thioesterase and hydrolyze acyl-CoA, an obligate acyl-donor in glycerolipid biosynthesis. The decrease of cellular TG levels in AADA expressing cells was accompanied by attenuated secretion of newly synthesized TG and increased fatty acid oxidation. Thus, AADA
does not appear to participate in the lipolysis/reesterification cycle in support of VLDL assembly, but rather, AADA activity seems to limit the deposition of TG into cytosolic lipid droplet and VLDL. Interestingly, inhibition of lipase activity by E600 has lowered fatty acid oxidation in AADA-expressing cells to levels seen in control cells. This is the first time that a membrane-localized carboxylester hydrolase has been linked to the release of fatty acids for β-oxidation.
In conclusion, our results indicate that expression of AADA, even at levels substantially lower than those present in the liver, decreases intracellular TG levels, decreases VLDL-TG secretion, and increases fatty acid oxidation. This study demonstrates that although AADA is an additional carboxylester hydrolase besides TGH that resides within the ER, the functions of AADA and TGH in TG metabolism differ. In spite of earlier data implying a possible role for AADA in supporting VLDL assembly (28), our current results suggest that AADA functions as a negative regulator of VLDL assembly and cellular TG storage. It is yet unclear why the liver would harbour an ER-localized enzyme whose function would be to break down mainly newly synthesized DG but it is possible that the enzyme has a role in futile cycling and diversion of fatty acids towards β-oxidation. Based on these results, AADA deserves further evaluation as a potential therapeutic target for combating hyperlipidemia and hepatic steatosis. The amount of radioactivity incorporated into TG (A), CE (B) and PC (C) was determined by scintillation counting. Due to slight variation in radioactivity incorporation in 3 independent experiments, the data presented are shown as percentages of the dpm counts per milligram of protein of control pCI-neo at 4 h pulse. The actual dpm/mg cell protein incorporated into cellular lipids for pCI-neo at 4 h pulse from 3 independent experiments performed in triplicates (mean±SD) were between 150,000±30,000 and 190,000±20,000 for TG, 50,000±9000 and 71,000±6300 for CE, and 100,000±5500 and 110,000±26,000 for PC. *p<0.001, **p<0.01 and ***p<0.05 compared to pCI-neo (pNeo) cells. inhibitor E600 (pulse), followed by incubation in DMEM with or without a lipase inhibitor E600 (Chase). Media equivalent to 500 µg of cell protein were analyzed for radioactivity in acidsoluble metabolites (ASM) as described under Materials and Methods. Due to slight variation in radioactivity incorporation in 3 independent experiments, the data presented are shown as percentages of control pCI-neo at 4 h pulse. The averages of the actual dpm/mg cell protein in ASM for pCI-neo at 4-hour pulse from 3 independent experiments performed in triplicates (mean ± SD) were between 610,000±70,000 and 880,000±100,000. *p<0.001, **p<0.01 and ***p<0.05. 
